INMED PHARMACEUTICALS INC. Fair Value Adjustment of Warrants
INMED PHARMACEUTICALS INC. (INM) reported Fair Value Adjustment of Warrants of $1.25 million for the 6-month period ending 2023-12-31, per its 10-Q filed 2024-02-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-02-13
- INMED PHARMACEUTICALS INC. fair value adjustment of warrants for the quarter ending 2021-03-31 was $0.00.
| Period end | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month |
|---|---|---|---|---|
| 2023-12-31 | $1.25M 10-Q · filed 2024-02-13 | |||
| 2021-07-02 | $739.92K 10-K · filed 2022-09-23 | |||
| 2021-06-02 | $739.92K 10-Q · filed 2021-11-10 | |||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-K 6 month · filed 2021-05-13 | $48.61K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $48.61K 10-K · filed 2021-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |